Industry Press Releases

From the first years of interventional cardiovascular medicine, our industry partners have played an important role in responding to the unmet needs of our speciality. Industry press releases form an inestimable resource for keeping up to date with the industry viewpoint on these latest developments in interventional cardiology. They include information on new medical technologies and treatments, clinical studies, publications and, of course, medical devices.

In this section you will find all the Industry Press releases published on this website with the content listed in chronological order.

These Industry Press Releases do not reflect the opinion of PCR, nor does it engage its responsibility.

Filter By

129 results

Biosensors International Announces Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™

03 May 2022

LimFlow Raises $40 Million (€36 Million) in Series D Financing

11 Apr 2022

egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the United States

04 Apr 2022

Elixir medical strengthens its commercial capabilities with the addition of Alaeddin Ahram as executive vice president, International

24 Mar 2022

Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+

16 Mar 2022

LimFlow completes enrollment in PROMISE II U.S. Pivotal trial of breakthrough device designed to prevent amputations in no-option patients with chronic limb-threatening ischemia

15 Mar 2022

CATHI Launches First New Generation Right Heart Catheter Simulator

09 Mar 2022

TRIA Transcatheter Biopolymer Heart Valve Shows Promise in Pilot Animal Study

28 Feb 2022

BIOTRONIK's New Absorbable Magnesium Scaffold Achieves Major Milestone in BIOMAG-I Clinical Trial

01 Mar 2022

BIOTRONIK Sets New Clinical Benchmark with Ultrathin Strut Orsiro Coronary Drug-Eluting Stent

28 Feb 2022